For example, an overexpression of folate receptor alpha (FRα) has been seen in some ovarian, lung and breast cancer cells; this can be exploited by functionalizing a drug carrier with folate, which binds specifically to FRα, for active drug targeting [101]. This evidence concerns the gene FOLR1 and breast carcinoma.